Feig Stephen A
University of California Irvine, Department of Radiological Sciences, Orange, CA.
J Breast Imaging. 2019 Jun 4;1(2):78-83. doi: 10.1093/jbi/wbz010.
The majority of randomized control trials and service-based screening studies of women ages 40-49 years demonstrate reductions in mortality of 29%-48% when long-term outcome is assessed. Annual screening is preferable in these younger women due to faster tumor-doubling times. Advances in mammography technique and breast ultrasound may allow even better results in the future.
大多数针对40至49岁女性的随机对照试验和基于服务的筛查研究表明，在评估长期结果时，死亡率可降低29%至48%。由于肿瘤倍增时间较短，对这些较年轻的女性而言，每年进行筛查更为可取。乳房X光检查技术和乳房超声检查的进展未来可能会带来更好的结果。
